COCH Dividend: Envoy Medical Inc Yield Insights

Income

Balance sheet

Cash flow

Annual

Quarterly

COCH Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	0	0	0	0	0	0
Revenue Growth (YoY)	--	--	--	--	--	--
Cost of Revenue	0	0	0	--	--	--
Gross Profit	0	0	0	--	--	--
Selling, General & Admin	8	8	8	--	--	--
Research & Development	10	10	8	--	--	--
Operating Expenses	19	18	17	4	5	0
Other Non Operating Income (Expenses)	0	0	-11	0	0	--
Pretax Income	-21	-20	-29	20	0	0
Income Tax Expense	--	0	0	1	--	--
Net Income	-28	-27	-31	19	0	0
Net Income Growth	75%	-13%	-263%	--	--	--
Shares Outstanding (Diluted)	21.38	18.79	12.29	53.13	45.81	52.5
Shares Change (YoY)	9%	53%	-77%	16%	-13%	--
EPS (Diluted)	-1.31	-1.48	-2.54	0.36	-0.01	0
EPS Growth	60%	-41%	-806%	-3,700%	--	--
Free Cash Flow	-16	-18	-17	-2	-3	0
Free Cash Flow Per Share	-0.74	-0.95	-1.38	-0.03	-0.06	0
Gross Margin	0%	0%	0%	--	--	--
Operating Margin	0%	0%	0%	0%	0%	0%
Profit Margin	0%	0%	0%	0%	0%	0%
Free Cash Flow Margin	0%	0%	0%	0%	0%	0%
EBITDA	-19	-19	-18	--	--	--
EBITDA Margin	0%	0%	0%	--	--	--
D&A For EBITDA	0	0	0	--	--	--
EBIT	-19	-19	-18	-4	-5	0
EBIT Margin	0%	0%	0%	0%	0%	0%
Effective Tax Rate	--	0%	0%	5%	--	--